We report on 4 children who presented with aseptic panniculitis associated with inherited immunodeficiency. Three patients had a B-cell immunodeficiency resulting from mutations in the TRNT1 and NF-κb2 genes (no mutation was found in the third patient), and 1 had a T-cell deficiency (mutation in the LCK gene). Panniculitis occurred before the age of 2 years in the 4 patients and preceded the onset of recurrent infections because of immunodeficiency in 2. It presented either as nodules, which resolved spontaneously within 1 to 2 weeks (3 patients), or chronic ulcerative lesions (1 patient) associated with unexplained fever and elevated acute phase reactants, without evidence of infection or high-titer autoantibodies. Febrile nodules relapsed in 2 patients, and recurrent attacks of unexplained fever (without relapse of panniculitis) occurred in the third. Skin biopsy revealed predominantly lympho-histiocytic or septal neutrophilic panniculitis in 1 and 3 patients, respectively. Panniculitis was associated with dermal involvement in the 4 patients. Patients with B-cell deficiency received monthly intravenous immunoglobulin replacement. Two patients who underwent bone marrow transplant died of bone marrow transplant-related complications. The 2 remaining patients had persistent, mild autoinflammatory disease, which did not require specific treatment. In these cases, the need for careful immunologic evaluation of patients who present with unexplained panniculitis, especially early-onset panniculitis before the age of 2 years, is highlighted.
- CRP —
- C-reactive protein
- IgA —
- immunoglobulin A
- IgG —
- immunoglobulin G
- IgM —
- immunoglobulin M
- IVIg —
- intravenous immunoglobulin
- WES —
- whole exome sequencing
Pediatric panniculitis occurs in a group of rare disorders characterized by inflammation of the subcutaneous fat.1,2 Histopathological analysis is required to confirm the diagnosis because the lesions may present differently, often consisting of erythematous nodules or large infiltrated plaques. Panniculitis cases are classified as mostly lobular, mostly septal, or mixed, depending on the distribution of the dominant subcutaneous inflammatory infiltrates.3 Panniculitis can be a primary disease but is most often a secondary process related to many different underlying disorders. Some types of panniculitis are specific to children, including those only seen in neonates such as subcutaneous fat necrosis of the newborn, or occur in a specific context such as postcorticosteroid panniculitis and cold panniculitis.1,2 Other recognized etiologies described in adults may be observed in children but are less frequent or rare in this population, including: infectious, connective tissue disease–related, subcutaneous lymphoma–like, metabolic (alpha1-antitrypsin deficiency, pancreatitis), and drug- or trauma-induced panniculitis. In many pediatric patients, no classic, specific cause can be identified. Such cases are designated as idiopathic panniculitis. Here, we describe the cases of 4 patients who presented with early-onset panniculitis associated with inherited B- or T-cell immunodeficiency. We propose that inherited immunodeficiency is a new cause of panniculitis, underlying the need for careful immunologic evaluation for cases of unexplained pediatric panniculitis, particularly with onset before the age of 2 years.
We identified 4 patients who displayed inherited immunodeficiency associated with panniculitis among 18 cases of pediatric idiopathic panniculitis (onset before the age of 16 years) recorded in the database of the Department of Dermatological Pathology of the Necker-Enfants Malades hospital from January 2004 to December 2014. Specific infectious causes for the panniculitis lesions were excluded by specific stains (periodic acid–Schiff, Grocott, Ziehl, and Gram) in cases of neutrophilic and/or macrophagic infiltrates, and Epstein-Barr encoding region staining was used for those composed of lymphocytes. Blood cultures and serological tests for Epstein-Barr virus, human herpesvirus 6, and cytomegalovirus were performed if an infection was suspected. Specific gene sequencing or whole exome sequencing (WES) was performed on DNA of the 4 patients after obtaining informed consent from the patients’ parents.
The 4 patients were referred to the Department of Pediatric Immunology and Rheumatology of the Necker-Enfants Malades hospital at the onset of disease. All were born to healthy, nonconsanguineous parents. Their demographic, biochemical, immunologic, pathologic, and genetic features are shown in Table 1.
A 2-month-old girl was referred because of fever and an erythematous nodule on 1 toe lasting 2 weeks (Fig 1). C-reactive protein (CRP) was 42 mg/L. A skin biopsy revealed predominantly septal lympho-histiocytic panniculitis (Fig 1). The symptoms resolved spontaneously within 4 weeks. During the course of the disease, the patient presented with relapsing noninfectious panniculitis coinciding with febrile attacks without any other manifestations and elevated acute-phase reactants without any other manifestations. Two to 4 episodes per year occurred and resolved spontaneously within 1 to 2 weeks. Other findings included recurrent otitis and ataxia, and we performed immunologic tests that revealed hypogammaglobulinemia and CD27+ memory B-cell deficiency (Table 1). Replacement intravenous immunoglobulin (IVIg) therapy was started (400 mg/kg per day). At 8 years of age, she was normal-sized for her age, and no more infections had occurred. Relapsing panniculitis and a mild ataxia persisted. WES was performed but did not allow identification of the underlying genetic defect.
A 20-month-old boy was referred because of undocumented lower respiratory tract infections, Salmonella infections, and failure to thrive. From the age of 10 months, he had a history of noninfectious, relapsing episodes of fever associated with multiple erythematous nodules (hands, feet, bottom) (Fig 1) and undocumented diarrhea. CRP levels rose substantially during these attacks (Table 1). A skin biopsy of 1 nodule revealed septal and lobular neutrophilic panniculitis (Fig 1). Immunologic investigation revealed a deficiency of serum immunoglobulin G (IgG), immunoglobulin A (IgA), and immunoglobulin M (IgM); poor vaccine responses; and abnormally low levels of CD27+ B cells and switch memory B cells. IVIg was started (400 mg/kg per day). He developed further chronic fever, diarrhea, arthritis, failure to thrive, and multiple ulcerative plaques (Fig 1) that did not undergo biopsy. At onset, he responded to treatment with high doses of prednisone (2 mg/kg per day) and treatment with interleukin-1β inhibitors (anakinra, canakinumab), anti–tumor necrosis factor inhibitors (infliximab), and cyclophosphamide were not steroid-sparing. He underwent a bone marrow transplant but died of treatment-related complications within the first days of the procedure. WES identified a mutation in the NF-κB2 gene.
A 12-month-old girl was referred because of recurrent attacks of fever from the age of 2 months, with or without documented infections, and failure to thrive. CRP levels were elevated during each episode. Infections consisted of recurrent septicemias. Aseptic febrile manifestations were vulvitis, parotitis, adenitis, and the occurrence of 1 noninfectious erythematous nodule of the limb (at 10 months). A skin biopsy of the nodule revealed lobular and septal neutrophilic panniculitis. Other features included chronic microcytic anemia (from the age of 2 months), low levels of serum IgG, IgA, and IgM, and low levels of CD27+ B cells and memory B cells. IVIg was started (400 mg/kg per day). At 6 years of age, her height was normal, and no infections had occurred. She continued to have 3 to 4 febrile attacks (lasting for 1 to 2 days) each month, associated with elevated CRP levels. There were no further episodes of panniculitis or other inflammatory manifestations associated with fever, and the anemia resolved spontaneously. WES identified a compound heterozygous mutation in the TRNT1 gene.
A 22-month-old girl was referred because of daily spiking fever, accompanied by multiple ulcerative skin nodules and inflammation of the interphalangeal joints (Fig 1). No infection was found, and these manifestations persisted despite intravenous antibiotic therapy (ceftriaxone, gentamycin, vancomycin, clarithromycin, ciprofloxacin, rifampicin, isoniazid). From the age of 15 months, she had undocumented protracted diarrhea and recurrent undocumented upper and lower respiratory tract infections, resulting in failure to thrive. A skin biopsy of a lesion revealed lobular neutrophilic panniculitis without granuloma (Fig 1). She had elevated CRP levels, and immunologic studies revealed CD4+ T-cell lymphopenia and low CD4 and CD8 expression. A LCK gene defect was identified. Given the severe T-cell deficiency, the patient underwent bone marrow transplant but died shortly after the procedure from treatment-related complications.
We report on 4 patients with an inherited B- or T-cell deficiency that was associated with aseptic panniculitis. Classic causes of panniculitis in children include infection, inflammatory rheumatic disorders, α1-antitrypsin deficiency, T-cell cytotoxic lymphoma, trauma- and cold-induced panniculitis, subcutaneous fat necrosis of the newborn, corticosteroid use, and erythema nodosum. Inherited immunodeficiency has not previously been considered as being associated with panniculitis.1,2 Indeed, the association of aseptic panniculitis with inherited immunodeficiency has been reported only for GATA2 and CECR1 mutations. GATA2 mutations result in a broad phenotype that encompasses immunodeficiency, myelodysplastic syndrome, pulmonary disease, and vascular and/or lymphatic dysfunction.3 CECR1 mutations result in adenosine deaminase 2 deficiency associated with a spectrum of vascular and inflammatory phenotypes, ranging from early-onset recurrent stroke to systemic vasculopathy or vasculitis, and is associated with hypogammaglobulinemia in some patients.4
Panniculitis occurred before 2 years of age in the 4 patients and preceded the manifestation of immunodeficiency (infections) in 2. At the onset of the disease, panniculitis presented as relapsing nodules that coincided with febrile attacks in 2 patients who had a B-cell deficiency and as chronic ulcerative plaques associated with fever in the patient with a T-cell deficiency. In the fourth patient, a single episode of febrile aseptic neutrophilic panniculitis occurred in addition to recurrent noninfectious febrile attacks associated with systemic inflammation. These episodes of panniculitis that are associated with an unexplained fever and systemic inflammation, without evidence of high-titer autoantibodies or autoantigen-specific T cells, are suggestive of autoinflammatory manifestations. Until now, early-onset panniculitis associated with systemic inflammation had been reported only in 4 autoinflammatory diseases that did not display an immunodeficiency phenotype: (1) chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature, characterized by early-onset, recurrent fever, skin lesions, lipodystrophy, and multisystemic inflammatory manifestations, resulting from autosomal recessive mutations in proteasome genes5; (2) familial Mediterranean fever, which classically consists of short, recurrent febrile episodes, serositis, and arthritis resulting from mutations in marenostrin-encoding fever gene6; (3) otulipenia, which presents as neonatal-onset fever, neutrophilic dermatitis and/or panniculitis, and failure to thrive because of mutations in OTULIN, encoding a deubiquitinase7; and (4) granulomatous panniculitis in infants who present with infantile-onset of widespread lobular panniculitis, panuveitis, arthropathy, and severe systemic illness.8
Skin biopsy revealed predominantly lympho-histiocytic or septal neutrophilic panniculitis in 1 and 3 patients, respectively. A histologic classification scheme has been proposed, dividing the cases into mostly lobular, septal, or mixed panniculitis, depending on the distribution of the dominant subcutaneous inflammatory infiltrate, with or without vasculitis.2 This classification is helpful to guide the etiological investigation in most of the cases. In our series, none of the 4 patients displayed a “pure” panniculitis without dermal involvement, and we could not identify a clear correlation between the nature of inflammatory infiltrate and the diagnosis of primary immunodeficiency because the panniculitis was either mostly neutrophilic or mostly lymphocytic in the 3 patients who presented with a B-cell deficiency.
Mutations were identified in 3 patients, whereas we failed to identify any mutation in the fourth patient using WES. Mutations were found in the LCK, TRNT1, and NF-κB2 genes. Panniculitis has been previously reported in 1 patient who had a mutation in LCK9 but not in those with mutations in the TRNT1 or NF-κB2 genes. The LCK gene defect is a T-cell immunodeficiency characterized by lymphopenia, low levels of CD4 and CD8 expression at the cell surface, and a lack of response to T-cell receptor activation.9 Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency (B-cell lymphopenia), periodic fevers, and developmental delay.10 Mutations in the NF-κB2 gene cause the recently defined clinical syndrome, common variable immunodeficiency, with central adrenal insufficiency.11 Thus, the occurrence of autoinflammatory panniculitis expands the phenotypes associated with mutations in TRNT1 and NF-κB2.
In these cases, we demonstrate that early-onset childhood panniculitis may reveal inherited immunodeficiency, and we highlight the need for careful immunologic evaluation of patients who present with unexplained panniculitis, even before clinical manifestations of immunodeficiency have emerged.
We thank Pr Capucine Picard for studying immunophenotyping of the patients.
- Accepted August 28, 2017.
- Address correspondence to Brigitte Bader-Meunier, MD, Hémato-Immunologie Pédiatrique, Hôpital Necker APHP, 149 rue de Sèvres, 75015 Paris, France. E-mail:
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: No external funding.
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
- Spinner MA,
- Sanchez LA,
- Hsu AP, et al
- Liu Y,
- Ramot Y,
- Torrelo A, et al
- Leiva-Salinas M,
- Betlloch I,
- Arribas MP,
- Francés L,
- Pascual JC
- Zhou Q,
- Yu X,
- Demirkaya E, et al
- Chakraborty PK,
- Schmitz-Abe K,
- Kennedy EK, et al
- Copyright © 2018 by the American Academy of Pediatrics